World Journal of Dentistry

Register      Login

VOLUME 9 , ISSUE 4 ( July-August, 2018 ) > List of Articles

REVIEW ARTICLE

Troubleshooting in Immunohistochemistry with their Remedies

Shankargouda B Patil, Vanishri C Haragannavar, Shwetha K Nambiar

Keywords : Analytical phase, Antigen retrieval, Immunohistochemistry, Postanalytical phase, Preanalytical phase, Remedies, Troubleshooters

Citation Information : Patil SB, Haragannavar VC, Nambiar SK. Troubleshooting in Immunohistochemistry with their Remedies. World J Dent 2018; 9 (4):333-341.

DOI: 10.5005/jp-journals-10015-1558

License: CC BY-SA 4.0

Published Online: 00-08-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim: The aim of the present study was to review the importance of various steps involved in immunohistochemistry (IHC) and highlight the troubleshootings encountered at each phase of the procedure with possible remedies. Introduction: Immunohistochemistry is often employed to explore tissue/cell antigens that vary from amino acids, proteins, infectious agents, and specific cellular group in health and disease. It is a vital tool for scientific research and also an adjunct technique for the exclusion of differential diagnosis that may be missed by routine stains. Although IHC is well practiced, there are several hurdles that could be encountered during each step of immunohistochemical procedure, i.e., preparation of slide to incubation with antibodies, interpretation and quantification of the desired expression that finally influences the staining of tissue. Clinical significance: An accurate and proper diagnosis of a pathology is key for the successful treatment by a clinician/ surgeon, as IHC acts as an adjunct in the diagnosis of challenging lesions. Hence, it is absolute necessary for a pathologist to have a thorough knowledge of immunohistochemical procedure and remedies to overcome the hurdles encountered during the procedure to obtain an ideal IHC-stained slide for diagnosis.


PDF Share
  1. Miller RT. Technical immunohistochemistry. Achieving reliability and reproducibility of immunostains. Society for Applied Immunohistochemistry. Annual Meeting New York Cornell-Queens Hospital Medical Center, Flushing, NY; 2001. pp. 1-50.
  2. Nadji M, Nassiri M, Vincek V, Kanhoush R, Morales AR. Immunohistochemistry of tissue prepared by a molecularfriendly fixation and processing system. Appl Immunohistochem Mol Morphol 2005 Sep;13(3):277-282.
  3. Howat WJ, Wilson BA. Tissue fixation and the effect of molecular fixatives on downstream staining procedures. Methods 2014 Nov;70(1):12-19.
  4. Daneshtalab N, Doré JJ, Smeda JS. Troubleshooting tissue specificity and antibody selection: procedures in immunohistochemical studies. J Pharmacol Toxicol Methods 2010 Apr;61(2):127-135.
  5. Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 2000 Jul;24(7):1016-1019.
  6. Chatterjee S. Artefacts in histopathology. J Oral Maxillofac Pathol 2014 Sep;18(4):111-116.
  7. Kyclová J, Rotterová P, Dvoøák K, Lukáš Z. Effect of fixation and autolysis on immunohistochemical detection of CD antigens. Scripta Medica (Brno) 2004 Apr;77(2):63-74.
  8. Farrell DJ, Thompson PJ, Morley AR. Tissue artefacts caused by sponges. J Clin Pathol 1992 Oct;45(10):923-924.
  9. Shi SR, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry: past, present and future. J Histochem Cytochem 1997 Mar;45(3):327-343.
  10. Shi SR, Cote RJ, Taylor CR. Antigen retrieval techniques: current perspectives. J Histochem Cytochem 2001 Aug;49(8): 931-937.
  11. Gown AM, de Wever N, Battifora H. Microwave-based antigenic unmasking a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1993 Jan;1(4):256-266.
  12. Okoye JO, Nnatuanya IN. Immunohistochemistry: a revolutionary technique in laboratory medicine. Clin Med Diagn 2015;5(4):60-69.
  13. R&D Systems. Canada USA. Available from: https://www. rndsystems.com/resources/protocols/preventing-nonspecific- staining [accessed 4 November 2016].
  14. Novus Biologicals a bio-technical brand, USA. Available from: https://www.novusbio.com/blocking-non-specificbinding2009 [accessed 15 December 2016].
  15. IHC world Life science product & services. Available from: http://www.ihcworld.com/_technical_tips/peroxidase_tips. html [accessed 10 November 2016].
  16. Radulescu RT, Boenisch T. Blocking endogenous peroxidases: a cautionary note for immunohistochemistry. J Cell Mol Med 2007 Nov;11(6):1419.
  17. Kalyzuzhny AE. Primary antibodies. In Immunohistochemistry. Techniques in life science and biomedicine for nonexpert; 2016. pp. 3-9.
  18. Mirlacher M, Kasper M, Storz M, Knecht Y, Dürmüller U, Simon R, Mihatsch MJ, Sauter G. Influence of slide aging on results of translational research studies using immunohistochemistry. Mod Pathol 2004 Jun;17(11):1414-1420.
  19. Immunohistochemistry AB. Immunohistochemistry Staining Methods. Education Guide, 5th ed.; 2009. p. 57.
  20. Hewitt SM, Baskin DG, Frevert CW, Stahl WL, Rosa-Molinar E. Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays. J Histochem Cytochem 2014 July;62(10): 693-697.
  21. Lin F, Chen Z. Standardization of diagnostic immunohistochemistry: literature review and Geisinger experience. Arch Pathol Lab Med 2014 Dec;138(12):1564-1577.
  22. Xie R, Chung J-Y, Ylaya K, Williams RL, Guerrero N, Nakatsuka N, Badie C, Hewitt SM. Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem 2011 Apr;59(4):356-365.
  23. Sanderson C, Emmanuel J, Emmanual J, Campbell P. A historical review of paraffin and its development as an embedding medium. J Histotechnol 1988 Mar;11(1):61-63.
  24. Jones ML. How formalin affects the outcome of routine and special stains. Biotech Histochem 2007 Jan;82(3):155-159.
  25. Anon. 1st ed. [ebook]. Available from: http://histologylab. ccnmtl.columbia.edu/HistologyLabManual.pdf. 2016.
  26. Montero C. The antigen-antibody reaction in immunohistochemistry. J Histochem Cytochem 2003 Jan;51(1):1-4.
  27. Economou M, Schöni L, Hammer C, Galván JA, Mueller DE, Zlobec I. Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains. Clin Transl Med 2014 Dec;3(1):1-3.
  28. Vara JAR, Webster JD, DuSold D, Miller MA. Immunohistochemical evaluation of the effects of paraffin section storage on biomarker stability. Vet Pathol 2014 Jan;51(1):102-109.
  29. Baunoch DA, Gooch G, Kraus CA, Kraus KJ, Stephens R. Troubleshooting problems in processing, staining.
  30. Wynnchuk M. Minimizing artifacts in tissue processing: part 2. Theory of tissue processing. J Histotechnol 1993 Mar;16(1):71-73.
  31. Sutin AR, Terracciano A, Ferrucci L, Costa PT Jr. Teeth grinding: is emotional stability related to bruxism? J Res Pers 2010 Jun;44(3):402-405.
  32. Uchida M, Yatani H, Ishigaki S, Toda M, Morimoto K. Relations among TMD, bruxism, lifestyle, and psychological stress. Prosthod Res Pract 2008 Nov;7(2):171-173.
  33. Ramseier CA, Kobrehel S, Staub P, Sculean A, Lang NP, Salvi GE. Compliance of cigarette smokers with scheduled visits for supportive periodontal therapy. J Clin Periodontol 2014 May;41(5):473-480.
  34. Rieder C, Joss A, Lang NP. Influence of compliance and smoking habits on the outcomes of supportive periodontal therapy (SPT) in a private practice. Oral Health Prev Dent 2004 Jan;2(2):89-94.
  35. Novaes AB Jr, Novaes AB. Compliance with supportive periodontal therapy. Part II: risk of non-compliance in a 10-year period. Braz Dent J 2001;12(1):47-50.
  36. Mendoza AR, Newcomb GM, Nixon KC. Compliance with supportive periodontal therapy. J Periodontol 1991 Dec;62(12):731-736.
  37. Novaes AB Jr, de Lima FR, Novaes AB. Compliance with supportive periodontal therapy and its relation to the bleeding index. J Periodontol 1996 Oct;67(10):976-980.
  38. Darcey J, Ashley M. See you in three months! The rationale for the three monthly peridontal recall interval: a risk based approach. Br Dent J 2011 Oct;211(8):379-385.
  39. Sebrechts H, Vlaminck S, Casselman J. Orbital edema resulting from Haller cell pathology: 3 case reports and review of literature. Acta Otorhinolaryngol Belg 2000;54(1):39-43.
  40. Cook PR, Nishioka GJ, Davis WE, McKinsey JP. Functional endoscopic sinus surgery in patients with normal computed tomography scans. Otolaryngol Neck Surg 1994 Jun; 110(6):505-509.
  41. Choi JH. Hypoesthesia of midface by isolated Haller's cell mucocele. Braz J Otorhinolaryngol 2016 Jul 22. pii:S1808- 8694(16)30138-0.
  42. Salonen MA, Oikarinen K, Virtanen K, Pernu H. Failures in the osseointegration of endosseous implants. Int J Oral Maxillofac Implants 1993;8(1):92-97.
  43. Zhang X, Sun Z, Yang Q. Application of Denaturing gradient gel electrophoresis to the analysis of bacterial communities associated with asymptomatic and symptomatic pericoronitis. J Oral Maxillofac Surg 2018 Mar;76(3):483-489.
  44. Suárez-López Del Amo F, Yu SH, Wang HL. Non-surgical therapy for peri-implant diseases: a systematic review. J Oral Maxillofac Res 2016 Sep;7(3):e13.
  45. Aberg CH, Kelk P, Johansson A. Aggregatibacter actinomycetemcomitans: virulence of its leukotoxin and association with aggressive periodontitis. Virulence 2015 Apr;6(3):188-195.
  46. Larsen OI, Enersen M, Kristoffersen AK, Wennerberg A, Bunæs DF, Lie SA, Leknes KN. Antimicrobial effects of three different treatment modalities on dental implant surfaces. J Oral Implantol 2017 Dec;43(6):429-436.
  47. Prathapachandran J, Suresh N. Management of periimplantitis. Dent Res J (Isfahan) 2012 Sep-Oct;9(5):516-521.
  48. Bhattacharyya M, Kumar AN, Kapuria S. Synthesis and characterization of Al/SiC and Ni/Al2O3 functionally graded materials. Mater Sci Eng A 2008 Jul;487(1-2):524-535.
  49. Chenglin C, Jingchuan Z, Zhongda Y, Shidong W. Hydroxyapatite-Ti functionally graded biomaterial fabricated by powder metallurgy. Mater Sci Eng A 1999 Nov;271(1):95-100.
  50. Oleiwi JK, Anaee RA, Muhsin SA. Fabrication, characterization and physical properties of functionally graded Ti/HAP bioimplants. Wulfenia J 2015 Jul;22(7):336-348.
  51. Ogawa T, Watanabe Y, Sato H, Kim IS, Fukui Y. Theoretical study on fabrication of functionally graded material with density gradient by a centrifugal solid-particle method. Compos Part A Appl S 2006 Dec;37(12):2194-2200.
  52. Yang ZM, Tian F, Zhang LM. Theoretical study on two sedimentation processes used to form functionally graded materials. J Mater Sci Lett 2003 May;22(10):739-741.
  53. Yang ZM, Gong DR, Zhang LM. Design of co-sedimentation experiments used to fabricate functionally graded materials with a continuous change of composition. J Wuhan Univ Technol Mater Sci Ed 2004 Jan;19(2):11-13.
  54. Jin G, Takeuchi M, Honda S, Nishikawa T, Awaji H. Properties of multilayered mullite/Mo functionally graded materials fabricated by powder metallurgy processing. Mater Chem Physics 2005 Feb;89(2):238-243.
  55. Jamaludin SN, Basri S, Hussain A, Al-Othmany DS, Mustapha F, Nuruzzaman DM. Three-dimensional finite element modeling of thermomechanical problems in functionally graded hydroxyapatite/titanium plate. Math Probl Eng 2014 Apr;2014:371462.
  56. Halpern LR, Dodson TB. Does prophylactic administration of systemic antibiotics prevent postoperative inflammatory complications after third molar surgery? J Oral Maxillofac Surg 2007 Feb;65(2):177-185.
  57. Lopez-Cedrun JL, Pijoan JI, Fernandez S, Santamaria J, Hernandez G. Efficacy of amoxycillin treatment in preventing postoperative complications in patients undergoing third molar surgery: a prospective, randomized, double-blind controlled study. J Oral Maxillofac Surg 2011 Jun;69(6):e5-e14.
  58. Arteagoitia MI, Barbier L, Santamaria J, Santamaria G, Ramos E. Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 2016 Jul;21(4):e494-e504.
  59. Piltz JR, Starita RJ. The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy. Ophthalmic Surg 1994 Jan;25(1):51-53.
  60. Por YM, Tan YL, Mehta JS, Tan DT. Intracameral fibrin tissue sealant as an adjunct in tectonic lamellar keratoplasty for large corneal perforations. Cornea 2009 May;28(4):451-455.
  61. Sakarya Y, Sakarya R, Yildirim A. Sutureless amniotic membrane fixation with fibrin glue in symptomatic bullous keratopathy with poor visual potential. Eur J Ophthalmol 2010 Jan-Feb;20(1):249; author reply 249-250.
  62. Lee GA, Holcombe DJ. Surgical revision of dysfunctional filtration blebs with bleb preservation sliding conjunctival flap and fibrin glue. Eye (Lond) 2010 Jun;24(6):947-953.
  63. Kahook MY, Noecker RJ. Fibrin glue-assisted glaucoma drainage device surgery. Br J Ophthalmol 2006 Dec;90(12):1486-1489.
  64. Valimaki J. Fibrin glue for preventing immediate postoperative hypotony following glaucoma drainage implant surgery. Acta Ophthalmol Scand 2006 Jun;84(3):372-374.
  65. Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant 2014 Jun;4(2):111-121.
  66. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol 2004 Jan-Feb;49(1):51-77.
  67. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 2001 May;20(4):408-413.
  68. Yazdani S, Mahboobipour H, Pakravan M, Doozandeh A, Ghahari E. Adjunctive mitomycin c or amniotic membrane transplantation for Ahmed glaucoma valve implantation: a randomized clinical trial. J Glaucoma 2016 May;25(5):415-421.
  69. Sheha H, Kheirkhah A, Taha H. Amniotic membrane transplantation in trabeculectomy with mitomycin C for refractory glaucoma. J Glaucoma 2008 Jun-Jul;17(4):303-307.
  70. Khairy HA, Elsawy MF. Trabeculectomy with mitomycin-C versus trabeculectomy with amniotic membrane transplant: a medium-term randomized controlled trial. J Glaucoma 2015 Sep;24(7):556-559.
  71. Rauscher FM, Barton K, Budenz DL, Feuer WJ, Tseng SC. Long-term outcomes of amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Am J Ophthalmol 2007 Jun;143(6):1052-1054.
  72. Sethi P, Patel RN, Goldhardt R, Ayyala RS. Conjunctival advancement with subconjunctival amniotic membrane draping technique for leaking cystic blebs. J Glaucoma 2016 Feb;25(2):188-192.
  73. Kitagawa K, Yanagisawa S, Watanabe K, Yunoki T, Hayashi A, Okabe M, Nikaido T. A hyperdry amniotic membrane patch using a tissue adhesive for corneal perforations and bleb leaks. Am J Ophthalmol 2009 Sep;148(3):383-389.
  74. Nagai-Kusuhara A, Nakamura M, Fujioka M, Negi A. Longterm results of amniotic membrane transplantation-assisted bleb revision for leaking blebs. Graefes Arch Clin Exp Ophthalmol 2008 Apr;246(4):567-571.
  75. Rai P, Lauande-Pimentel R, Barton K. Amniotic membrane as an adjunct to donor sclera in the repair of exposed glaucoma drainage devices. Am J Ophthalmol 2005 Dec;140(6): 1148-1152.
  76. Ainsworth G, Rotchford A, Dua HS, King AJ. A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery. Br J Ophthalmol 2006 Apr;90(4):417-419.
  77. Papadaki TG, Siganos CS, Zacharopoulos IP, Panteleontidis V, Charissis SK. Human amniotic membrane transplantation for tube exposure after glaucoma drainage device implantation. J Glaucoma 2007 Jan;16(1):171-172.
  78. Mulder EJ, Leiblum DM, Visser GH. Fetal breathing movements in late diabetic pregnancy: relationship to fetal heart rate patterns and Braxton Hicks’ contractions. Early Hum Dev 1995 Nov;43(3):225-232.
  79. Schulte FJ, Michaelis R, Nolte R, Albert G, Parl U, Lasson U. Brain and behavioral maturation in newborn infants of diabetic mothers. I. Nerve conduction and EEG patterns. Neuropadiatrie 1969 Jan-Jul;1(1):24-35.
  80. Devoe LD, Youssef AA, Castillo RA, Croom CS. Fetal biophysical activities in third-trimester pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 1994 Aug;171(2):298-303.
  81. Dierker LJ Jr, Pillay S, Sorokin Y, Rosen MG. The change in fetal activity periods in diabetic and nondiabetic pregnancies. Am J Obstet Gynecol 1982 May;143(2):181-185.
  82. Doherty NN, Hepper PG. Habituation in fetuses of diabetic mothers. Early Hum Dev 2000 Aug;59(2):85-93.
  83. Kainer F, Prechtl HF, Engele H, Einspieler C. Assessment of the quality of general movements in fetuses and infants of women with type-1 diabetes mellitus. Early Hum Dev 1997 Nov;50(1):13-25.
  84. Mulder EJ, O'Brien MJ, Lems YL, Visser GH, Prechtl HF. Body and breathing movements in near-term fetuses and newborn infants of type-1 diabetic women. Early Hum Dev 1990 Nov;24(2):131-152.
  85. Mulder EJ, Visser GH. Growth and motor development in fetuses of women with type-1 diabetes. I. Early growth patterns. Early Hum Dev 1991 May;25(2):91-106.
  86. Mulder EJ, Visser GH. Growth and motor development in fetuses of women with type-1 diabetes. II. Emergence of specific movement patterns. Early Hum Dev 1991 May;25(2):107-115.
  87. Mulder EJ, Visser GH. Impact of early growth delay on subsequent fetal growth and functional development: a study on diabetic pregnancy. Early Hum Dev 1992 Dec;31(2):91-95.
  88. Mulder EJ, Visser GH, Bekedam DJ, Prechtl HF. Emergence of behavioral states in fetuses of type-1 diabetic women. Early Hum Dev 1987 Jul;15(4):231-251.
  89. Mulder EJ, Visser GH, Morssink LP, de Vries JI. Growth and motor development in fetuses of women with type-1 diabetes. III. First trimester quantity of fetal movement patterns. Early Hum Dev 1991 May;25(2):117-133.
  90. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001 Mar;61(2):85-95.
  91. Deregnier RA, Nelson CA, Thomas KM, Wewerka S, Georgieff MK. Neurophysiologic evaluation of auditory recognition memory in healthy newborn infants and infants of diabetic mothers. J Pediatr 2000 Dec;137(6):777-784.
  92. Nelson CA, Wewerka S, Thomas KM, Tribby-Walbridge S, deRegnier R, Georgieff M. Neurocognitive sequelae of infants of diabetic mothers. Behav Neurosci 2000 Oct;114(5):950-956.
  93. Reece EA, Homko CJ. Infant of the diabetic mother. Semin Perinatol 1994 Oct;18(5):459-469.
  94. Reece EA, Homko CJ. Why do diabetic women deliver malformed infants? Clin Obstet Gynecol 2000 Mar;43(1):32-45.
  95. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 1991 Sep;325(13):911-916.
  96. Rizzo TA, Metzger BE, Dooley SL, Cho NH. Early malnutrition and child neurobehavioral development: insights from the study of children of diabetic mothers. Child Dev 1997 Feb;68(1):26-38.
  97. Schwartz R, Teramo KA. Effects of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000 Apr;24(2):120-135.
  98. Vaarasmaki MS, Hartikainen A, Anttila M, Pramila S, Koivisto M. Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev 2000 Jul;59(1):61-70.
  99. Robertson SS, Dierker LJ. Fetal cyclic motor activity in diabetic pregnancies: sensitivity to maternal blood glucose. Dev Psychobiol 2003 Jan;42(1):9-16.
  100. Accardo PJ, Blondis TA, Whitman BY. Disorders of attention and activity level in a referral population. Pediatrics 1990 Mar;85(3 Pt 2):426-431.
  101. Ornoy A, Uriel L, Tennenbaum A. Inattention, hyperactivity and speech delay at 2-4 years of age as a predictor for ADDADHD syndrome. Isr J Psychiatry Relat Sci 1993;30(3):155-163.
  102. Smyth TR. Impaired motor skill (clumsiness) in otherwise normal children: a review. Child Care Health Dev 1992 Sep-Oct;18(5):283-300.
  103. Petersen MB, Pedersen SA, Greisen G, Pedersen JF, Mølsted- Pedersen L. Early growth delay in diabetic pregnancy: relation to psychomotor development at age 4. Br Med J (Clin Res Ed) 1988 Feb;296(6622):598-600.
  104. Sells CJ, Robinson NM, Brown Z, Knopp RH. Long-term developmental follow-up of infants of diabetic mothers. J Pediatr 1994 Jul;125(1):S9-S17.
  105. Vladareanu R, Lebit D, Constantinescu S. Ultrasound assessment of fetal neurobehaviour in high risk pregnancies. DSJUOG 2012 Apr-Jun;6(2):132-147.
  106. Talic A, Kurjak A, Ahmed B, Stanojevic M, Predojevic M, Kadic AS, Di Renzo GC. The potential of 4D sonography in the assessment of fetal behavior in high-risk pregnancies. J Matern Fetal Neonatal Med 2011 Jul;24(7):948-954.
  107. Bekedam DJ, Visser GH, de Vries JJ, Prechtl HF. Motor behaviour in the growth retarded fetus. Early Hum Dev 1985 Nov;12(2):155-165.
  108. Cioni G, Prechtl HF. Preterm and early postterm motor behaviour in low-risk premature infants. Early Hum Dev 1990 Sep;23(3):159-191.
  109. Seme-Ciglenecki P. Predictive value of assessment of general movements for neurological development of highrisk preterm infants: comparative study. Croat Med J 2003 Dec;44(6):721-727.
  110. Abo-Yaqoub S, Kurjak A, Mohammed AB, Shadad A, Abdel-Maaboud M. The role of 4-D ultrasonography in prenatal assessment of fetal neurobehaviour and prediction of neurological outcome. J Matern Fetal Neonatal Med 2012 Mar;25(3):231-236.
  111. Athanasiadis AP, Mikos T, Tambakoudis GP, Theodoridis TD, Papastergiou M, Assimakopoulos E, Tarlatzis BC. Neurodevelopmental fetal assessment using KANET scoring system in low and high-risk pregnancies. J Matern Fetal Neonatal Med 2013 Mar;26(4):363-368.
  112. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012 Jan;97(1):28-38.e25
  113. Sirmans SM, Pate KA. Epidemiology, diagnosis and management of polycystic ovary syndrome. Clin Epidemiol 2014; 6:1-13.
  114. Fauser BC, Diedrich K, Bouchard P, Domínguez F, Matzuk M, Franks S, Hamamah S, Simón C, Devroey P, Ezcurra D, et al. Contemporary genetic technologies and female reproduction. Human Reproduction Update 2011 Nov;17(6):829-847.
  115. Balen A, Conway G, Kaltsas G. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995 Aug;10(8):2107-2111.
  116. Azziz R, Sanchez L, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004 Feb;89(2):453-462.
  117. Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at longterm follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 2000 May;52(5):595-600.
  118. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007 Jun;87(6): 1369-1376.
  119. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome. In: Givens JHF, Merriman G, editors. The polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific; 1992. p. 377-384.
  120. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 Jan;81(1):19-25.
  121. Azziz R, Carmina E, DeWailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006 Nov;91(11):4237-4245.
  122. Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, Haider E, Pierson RA, Chizen DR. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 2013 May;28(5):1361-1368.
  123. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health 2011 Feb;3:25-35.
  124. ACOG Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No 108: Polycystic ovary syndrome. Obstet Gynecol 2009 Oct;114(4):936-949.
  125. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008 Mar;89(3): 505-522.
  126. Balen AH. Ovulation induction in the management of anovulatory polycystic ovary syndrome. Mol Cell Endocrinol 2013 Jul;373(1-2):77-82.
  127. Berridge DL, Winter TC. Saline infusion sonohysterography: technique, indications, and imaging findings. J Ultrasound Med 2004 Jan;23(1):97-112.
  128. Allison SJ, Horrow MM, Kim HY, Lev-Toaff AS. Salineinfused sonohysterography: tips for achieving greater success. Radiographics 2011 Nov-Dec;31(7):1991-2004.
  129. O'Neill MJ. Sonohysterography. Radiol Clin North Am 2003 Jul;41(4):781-797.
  130. Bonnamy L, Marret H, Perrotin F, Body G, Berger C, Lansac J. Sonohysterography: a prospective survey of results and complications in 81 patients. Eur J Obstet Gynecol Reprod Biol 2002 Apr;102(1):42-47.
  131. Lindheim SR, Adsuar N, Kushner DM, Pritts EA, Olive DL. Sonohysterography: a valuable tool in evaluating the female pelvis. Obstet Gynecol Surv 2003 Nov;58(11):770-784.
  132. Lindheim SR, Sprague C, Winter TC. Hysterosalpingography and sonohysterography: lessons in technique. AJR Am J Roentgenol 2006 Jan;186(1):24-29.
  133. Jeanty P, Besnard S, Arnold A, Turner C, Crum P. Air-contrast sonohysterography as a first step assessment of tubal patency. J Ultrasound Med 2000 Aug;19(8):519-527.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.